Potent efficiency of the novel nitazoxanide-loaded nanostructured lipid carriers against experimental cyclosporiasis
PLOS Neglected Tropical Diseases · 2023
DOI: 10.1371/journal.pntd.0011845 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2023. Verfasst von Nancy Abd-Elkader Hagras und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Technology, Faculty of Applied Health Sciences Technology, Pharos University in Alexandria, Alexandria, Egypt. Hauptthemen laut MEDLINE: Cyclosporiasis, Cyclospora. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cyclosporiasis is a ubiquitous infection caused by an obligate intracellular protozoan parasite known as Cyclospora cayetanensis ( C . cayetanensis ). The disease is characterized by severe diarrhea which may be regrettably fatal in immunosuppressed patients. The commercially available treatment options have either severe side effects or low efficiency. In the present study, the novel formula of nitazoxanide (NTZ)-loaded nanostructured lipid carriers (NLCs) was assessed for the first time for C . cayetanensis treatment in both immunocompetent and immunosuppressed mice in comparison to commercially available drugs (trimethoprim-sulfamethoxazole (TMP-SMX) and NTZ). Swiss Albino mice were orally infected by 10 4 sporulated oocysts. The experimental groups were treated with the gold standard TMP-SMX, NTZ, blank NLCs and NTZ-loaded NLCs. The results demonstrated that NTZ-loaded NLCs represented the highest significant parasite percent reduction of (>98% reduction) in both immunocompetent and immunosuppressed mice designating successful tissue penetration and avoiding recurrence of infection at the end of the study. Oocysts treated with NTZ-loaded NLCs demonstrated the most mutilated rapturing morphology via scanning electron microscope examination as well as representing the most profound improvement of the histopathological picture. In conclusion, NTZ-loaded NLCs exhibited the uppermost efficacy in the treatment of cyclosporiasis. The safe nature and the anti-parasitic effect of the novel formulation encourage its use as a powerful treatment for human cyclosporiasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory Technology, Faculty of Applied Health Sciences Technology, Pharos University in Alexandria, Alexandria, Egypt.
- Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
- Department of Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
- Faculty of Science, Zagazig University, Zagazig, Egypt.
- Department of Medical Parasitology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
ORCID-Profile: Nancy Abd-Elkader Hagras
Zitieren
APA
Hagras, N. A., Makled, S., Sheta, E., El-Hawary, M. A., & Mogahed, N. M. F. H. (2023). Potent efficiency of the novel nitazoxanide-loaded nanostructured lipid carriers against experimental cyclosporiasis. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011845
Vancouver
Hagras NA, Makled S, Sheta E, El-Hawary MA, Mogahed NMFH. Potent efficiency of the novel nitazoxanide-loaded nanostructured lipid carriers against experimental cyclosporiasis. PLOS Neglected Tropical Diseases. 2023. doi:10.1371/journal.pntd.0011845
BibTeX
@article{Hagras2023,
author = {Hagras, Nancy Abd-Elkader and Makled, Shaimaa and Sheta, Eman and El-Hawary, Mohamed Ali and Mogahed, Nermine Mogahed Fawzy Hussein},
title = {Potent efficiency of the novel nitazoxanide-loaded nanostructured lipid carriers against experimental cyclosporiasis},
journal = {PLOS Neglected Tropical Diseases},
year = {2023},
doi = {10.1371/journal.pntd.0011845}
}
EUVIMED